UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737

Cancer research (Chicago, Ill.), 2007-02, Vol.67 (3), p.1176-1183

2007

Volltextzugriff (PDF)

X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death

Nature (London), 1996-05, Vol.381 (6580), p.335-341

1996

Volltextzugriff (PDF)

Bexarotene (LGD1069, Targretin), a selective retinoid X receptor agonist, prevents and reverses gemcitabine resistance in NSCLC cells by modulating gene amplification

Cancer research (Chicago, Ill.), 2007-05, Vol.67 (9), p.4425-4433

2007

Volltextzugriff (PDF)

Human Chk1 Expression Is Dispensable for Somatic Cell Death and Critical for Sustaining G2 DNA Damage Checkpoint

Molecular cancer therapeutics, 2003-06, Vol.2 (6), p.543-548

2003

Volltextzugriff (PDF)

Survivin Enhances Aurora-B Kinase Activity and Localizes Aurora-B in Human Cells

The Journal of biological chemistry, 2003-01, Vol.278 (1), p.486-490

2003

Volltextzugriff (PDF)

Highly sensitive proximity mediated immunoassay reveals HER2 status conversion in the circulating tumor cells of metastatic breast cancer patients

Proteome science, 2011-12, Vol.9 (1), p.75-75, Article 75

2011

Volltextzugriff (PDF)

Studies Leading to Potent, Dual Inhibitors of Bcl-2 and Bcl-xL

Journal of medicinal chemistry, 2007-02, Vol.50 (4), p.641-662

2007

Volltextzugriff (PDF)

Identification of Chaulmoogric Acid as a Small Molecule Activator of Protein Phosphatase 5

Applied biochemistry and biotechnology, 2010-03, Vol.160 (5), p.1450-1459

2010

Volltextzugriff (PDF)

Down-regulation of Survivin by Antisense Oligonucleotides Increases Apoptosis, Inhibits Cytokinesis and Anchorage-Independent Growth

Neoplasia (New York, N.Y.), 2000-05, Vol.2 (3), p.235-241

2000

Volltextzugriff (PDF)

NMR structure and mutagenesis of the FADD (Mort1) death-effector domain

Nature (London), 1998-04, Vol.392 (6679), p.941-945

1998

Volltextzugriff (PDF)

Development of a high-throughput fluorescence polarization assay for Bcl-xL

Analytical biochemistry, 2002-08, Vol.307 (1), p.70-75

2002

Volltextzugriff (PDF)

Potentiating the naturally occurring process for repair of damaged heart

Current pharmaceutical design, 2014-04, Vol.20 (12), p.1950-1963

2014

Volltextzugriff (PDF)

Discovery of novel inhibitors of Bcl-xL using multiple high-throughput screening platforms

Analytical biochemistry, 2004-05, Vol.328 (2), p.131-138

2004

Volltextzugriff (PDF)

Synthesis and Biological Evaluation of 2-Indolyloxazolines as a New Class of Tubulin Polymerization Inhibitors. Discovery of A-289099 as an Orally Active Antitumor Agent

Bioorganic & medicinal chemistry letters, 2002-02, Vol.12 (3), p.465-469

2002

Volltextzugriff (PDF)

Distinctive Roles of PHAP Proteins and Prothymosin-α in a Death Regulatory Pathway

Science (American Association for the Advancement of Science), 2003-01, Vol.299 (5604), p.223-226

2003

Volltextzugriff (PDF)

Novel One-Pot Total Syntheses of Deoxyvasicinone, Mackinazolinone, Isaindigotone, and Their Derivatives Promoted by Microwave Irradiation

Organic letters, 2005-07, Vol.7 (15), p.3363-3366

2005

Volltextzugriff (PDF)

Enhanced Secretory Production of a Single-Chain Antibody Fragment from Bacillus subtilis by Coproduction of Molecular Chaperones

Journal of Bacteriology, 1998-06, Vol.180 (11), p.2830-2835

1998

Volltextzugriff (PDF)

Rapid Colchicine Competition-Binding Scintillation Proximity Assay Using Biotin-Labeled Tubulin

BioTechniques, 2000-07, Vol.29 (1), p.156-160

2000

Volltextzugriff (PDF)

Biological Activity of A-289099: An Orally Active Tubulin-binding Indolyloxazoline Derivative

Molecular cancer therapeutics, 2003-03, Vol.2 (3), p.227-233

2003

Volltextzugriff (PDF)

Crystal structure of HsEg5 in complex with clinical candidate CK0238273 provides insight into inhibitory mechanism, potency, and specificity

Biochemical and biophysical research communications, 2008-08, Vol.372 (4), p.565-570

2008

Volltextzugriff (PDF)

NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP

Nature (London), 1999-10, Vol.401 (6755), p.818-822

1999

Volltextzugriff (PDF)

Identification of Polymorphisms Associated with Hypertriglyceridemia and Prolonged Survival Induced by Bexarotene in Treating Non-small Cell Lung Cancer

Anticancer research, 2011-06, Vol.31 (6), p.2303-2311

2011

Volltextzugriff (PDF)

Aryl tetrahydropyridine inhibitors of farnesyltransferase: glycine, phenylalanine and histidine derivatives

Bioorganic & medicinal chemistry letters, 2003-04, Vol.13 (7), p.1359-1362

2003

Volltextzugriff (PDF)

Crystal Structure and Mutagenic Analysis of the Inhibitor-of-Apoptosis Protein Survivin

Molecular cell, 2000, Vol.6 (1), p.173-182

2000

Volltextzugriff (PDF)

Blocking CHK1 Expression Induces Apoptosis and Abrogates the G2 Checkpoint Mechanism

Neoplasia (New York, N.Y.), 2001, Vol.3 (5), p.411-419

2001

Volltextzugriff (PDF)

1 – 25 von 114

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(109)

Publikationsform

Artikel
(113)
Dissertationen
(1)

Sprache

Englisch
(114)

Erscheinungsjahr

n.n

Thema

Science & Technology
(83)
Life Sciences & Biomedicine
(72)
Humans
(52)
Biological And Medical Sciences
(50)
Animals
(35)
Medical Sciences
(32)
Chemistry
(27)
Physical Sciences
(26)
Pharmacology. Drug Treatments
(24)
Biochemistry & Molecular Biology
(22)
Pharmacology & Pharmacy
(22)
Antineoplastic Agents
(20)
Amino Acid Sequence
(19)
Chemistry, Medicinal
(19)
Molecular Sequence Data
(19)
Fundamental And Applied Biological Sciences. Psychology
(18)
Antineoplastic Agents - Pharmacology
(17)
Apoptosis
(17)
Mice
(17)
Chemistry, Organic
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737

X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death

Bexarotene (LGD1069, Targretin), a selective retinoid X receptor agonist, prevents and reverses gemcitabine resistance in NSCLC cells by modulating gene amplification

Human Chk1 Expression Is Dispensable for Somatic Cell Death and Critical for Sustaining G2 DNA Damage Checkpoint

Survivin Enhances Aurora-B Kinase Activity and Localizes Aurora-B in Human Cells

Highly sensitive proximity mediated immunoassay reveals HER2 status conversion in the circulating tumor cells of metastatic breast cancer patients

Studies Leading to Potent, Dual Inhibitors of Bcl-2 and Bcl-xL

Identification of Chaulmoogric Acid as a Small Molecule Activator of Protein Phosphatase 5

Down-regulation of Survivin by Antisense Oligonucleotides Increases Apoptosis, Inhibits Cytokinesis and Anchorage-Independent Growth

NMR structure and mutagenesis of the FADD (Mort1) death-effector domain

Development of a high-throughput fluorescence polarization assay for Bcl-xL

Potentiating the naturally occurring process for repair of damaged heart

Discovery of novel inhibitors of Bcl-xL using multiple high-throughput screening platforms

Synthesis and Biological Evaluation of 2-Indolyloxazolines as a New Class of Tubulin Polymerization Inhibitors. Discovery of A-289099 as an Orally Active Antitumor Agent

Distinctive Roles of PHAP Proteins and Prothymosin-α in a Death Regulatory Pathway

Novel One-Pot Total Syntheses of Deoxyvasicinone, Mackinazolinone, Isaindigotone, and Their Derivatives Promoted by Microwave Irradiation

Enhanced Secretory Production of a Single-Chain Antibody Fragment from Bacillus subtilis by Coproduction of Molecular Chaperones

Rapid Colchicine Competition-Binding Scintillation Proximity Assay Using Biotin-Labeled Tubulin

Biological Activity of A-289099: An Orally Active Tubulin-binding Indolyloxazoline Derivative

Crystal structure of HsEg5 in complex with clinical candidate CK0238273 provides insight into inhibitory mechanism, potency, and specificity

NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP

Identification of Polymorphisms Associated with Hypertriglyceridemia and Prolonged Survival Induced by Bexarotene in Treating Non-small Cell Lung Cancer

Aryl tetrahydropyridine inhibitors of farnesyltransferase: glycine, phenylalanine and histidine derivatives

Crystal Structure and Mutagenic Analysis of the Inhibitor-of-Apoptosis Protein Survivin

Blocking CHK1 Expression Induces Apoptosis and Abrogates the G2 Checkpoint Mechanism

Suchergebnisse filtern